FIELD: medicine.
SUBSTANCE: group of inventions refers to medical equipment, namely to a coating of balloon catheters. A balloon catheter with a citrate ester and at least one of cytostatic, cytotoxic, antiproliferative, antiangiogenic, antirestenotic, antineoplastic, antimigratory or athrombogenic active substance. The group of inventions also refers applying the citrate ester and at least one of the specified active substances for the coating of the balloon catheter.
EFFECT: group of inventions provides reducing time of penetration of the biologically active substances in the vascular walls, and also preventing restenosis.
8 cl, 5 dwg, 3 tbl, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2447901C2 |
| STENT | 2007 |
|
RU2432183C9 |
| DEVICE FOR DELIVERY OF MEDICINAL PREPARATION, METHOD OF MANUFACTURE AND APPLICATION OF THE DEVICE | 2003 |
|
RU2316358C2 |
| IMPROVED DRUG-COATED MEDICAL DEVICES, MAKING AND USING THEM | 2008 |
|
RU2471508C2 |
| CATHETER CYLINDER | 2011 |
|
RU2633723C2 |
| MEDICINAL PRODUCT WITH PARTICLE-FREE COATING RELEASING ACTIVE SUBSTANCE | 2011 |
|
RU2578422C2 |
| BALLOON CATHETER COATED WITH ANTIRESTENOSIS ACTIVE INGREDIENT AND TRANSPORT PROMOTING MOLECULAR DISPERSING AGENT | 2011 |
|
RU2543330C2 |
| IMPLANTS WITH FK506 | 2002 |
|
RU2332959C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
| COATING FOR MEDICAL DEVICE CONTAINING ANTITHROMBOTIC CONJUGATE | 2008 |
|
RU2472529C2 |
